38 results on '"Steg P.G."'
Search Results
2. Sotagliflozin Significantly Reduces CV Death and Heart Failure-related Outcomes in Patients with Type 2 Diabetes, Chronic Kidney Disease, and History of Heart Failure
3. Multicenter randomized controlled trial on Duration of Therapy for Thrombosis in Children and Young Adults (the Kids‐DOTT trial): pilot/feasibility phase findings
4. Two-year Vascular Hospitalisation Rates and Associated Costs in Patients at Risk of Atherothrombosis in France and Germany: Highest Burden for Peripheral Arterial Disease
5. Effect of heart rate reduction by ivabradine on left ventricular remodeling in the echocardiographic substudy of BEAUTIFUL
6. Standard modifiable risk factors and mortality in patients with ST-segment elevation myocardial infarction: Findings from the FRENCHIE cohort
7. Incidence and predictors of in-hospital complications after myocardial infraction in contemporary clinical practice: Findings from the FRENCHIE myocardial infarction cohort
8. Burden of dementia, chronic kidney disease and cardiovascular diseases attributable to systolic hypertension in France
9. Syndromes coronariens aigus et phéochromocytome
10. Prevalence, incidence and prognostic implications of left bundle branch block in patients with stable coronary artery disease. An analysis from the CLARIFY registry
11. NAXOS: Healthcare resource use among patients with non-valvular atrial fibrillation newly treated with apixaban in France, and comparison with other oral anticoagulants
12. Frequency, management and outcomes of patients with stable coronary artery disease eligible for COMPASS. An analysis of the CLARIFY Registry
13. Use of risk score to identify lower and higher risk subsets among COMPASS-Eligible patients with stable CAD. Insights from the CLARIFY Registry
14. PCV16 MULTIPLE STATISTICAL APPROACHES IN COMPARATIVE EFFECTIVENESS RESEARCH (CER): THE EXAMPLE OF NAXOS, A LARGE FRENCH CER
15. Use of oral anticoagulants in the treatment of non-valvular atrial fibrillation in France: Patient characteristics from the NAXOS cohort study
16. How frequent are COMPASS-like patients in the real world? Insights from the reduction of atherothrombosis for continued health (REACH) registry
17. PULSE PRESSURE IN ACUTE CORONARY SYNDROMES: COMPARATIVE PROGNOSTIC SIGNIFICANCE WITH SYSTOLIC BLOOD PRESSURE
18. NEW ONSET ATRIAL FIBRILLATION IN ACUTE CORONARY SYNDROME: FINDINGS FROM THE GRACE ECG SUBSTUDY
19. PROGNOSTIC VALUE OF T-WAVE INVERSION ON THE PRESENTING VERSUS FOLLOW-UP ECG IN NON-ST ELEVATION ACUTE CORONARY SYNDROMES
20. WITHDRAWN: The beautiful study: Baseline characteristics of included patients
21. PCV65 Service Utilization, Predictors and Costs among High-Risk Patients with Cardiovascular Disease: Using Real World Data from the Australian Reach Registry
22. 483 PREVALENCE OF ELEVATED C-REACTIVE PROTEIN LEVELS IN A PRIMARY CVD PREVENTION POPULATION IN EUROPE: THE EURIKA STUDY
23. O51 Syndrome coronarien aigu chez les diabétiques : est-ce que son pronostic s’améliore avec le temps ?
24. We-P13:365 Prevalence and characteristic features of metabolic syndrome with and without diabetes in patients with acute myocardial infarction
25. We-P11:113 Influence of metabolic syndrome with and without diabetes on hospital outcomes after acute myocardial infarction
26. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events
27. Impact of prehospital thrombolysis for acute myocardial infarction on 1-year outcome: Results from the French nationwide USIC 2000 registry
28. Medication Performance Measures and Mortality Following Acute Coronary Syndromes
29. Prevalence and Impact of Metabolic Syndrome on Hospital Outcomes in Acute Myocardial Infarction
30. DECOPI (DEsobstruction COronaire en Post-Infarctus): A Randomized Multi-centre Trial of Occluded Artery Angioplasty After Acute Myocardial Infarction
31. Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the captim randomized clinical trial
32. Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the global registry of acute coronary events (GRACE)
33. Angor instable. Introduction
34. Reperfusion syndrome in acute myocardial infarction: a transient impairment of the microvasculature associated with a larger infarct size and sustained LV dysfunction
35. Procalcitonin: infections in acute coronary syndromes
36. Should we stent all the patients? Preliminary answer from the multicenter randomized FROST study
37. Improved collateral circulation and decreased no-reflow in inferior vs anterior infarction. A myocardial contrast echocardiography study
38. Equal sensitivity of resting dipyridamole and exercise thallium 201 myocardial perfusion imaging for detection of coronary artery disease. A prospective crossover study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.